Phase II study of 1,3‐Bis (2‐chloroethyl)‐1‐nitrosourea (BCNU, NSC #409962) with amphotericin B in bronchogenic carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|45|1|6-10

ISSN： 0008-543x

Source： CANCER, Vol.45, Iss.1, 1980-01, pp. : 6-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study with Interferon alpha-2a and 13-cis-Retinoic Acid in Patients with Metastatic Renal Cell Carcinoma. A Trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society

By  

Oncology Research and Treatment, Vol. 22, Iss. 5, 1999-11 ,pp. : 412-415

Karger

Access to resources Recommend Favorite

Temozolomide in Patients with Glioblastoma at Second Relapse after First Line Nitrosourea-Procarbazine Failure: A Phase II Study

By  

Oncology, Vol. 63, Iss. 1, 2002-08 ,pp. : 38-41

Karger

Access to resources Recommend Favorite

A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 3, 2018-02 ,pp. : 445-448

John Wiley & Sons Inc

Access to resources Recommend Favorite

1. Phase I and Phase II Study Groups

By  

Oncology Research and Treatment, Vol. 21, Iss. 3, 1998-07 ,pp. : 1-61

Karger

Access to resources Recommend Favorite

THE EARLY RECOGNITION OF BRONCHOGENIC CARCINOMA

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 1, Iss. 4, 1953-04 ,pp. : 250-258

John Wiley & Sons Inc

Access to resources Recommend Favorite